On January 8 2019, the State Scientific and Technological awards congress was held in a grand setting at the Great Hall of the People in Beijing. In total, 278 projects and seven scientific and technological experts were selected at this congress. Among those selected, the pantoprazole sodium and key preparation technologies research and industrialization project by Huadong Medicine Co., Ltd. (shortened to Huadong Medicine), affiliated with China Grand Enterprises, was awarded the second prize of the National Science and Technology Progress Award.

 (Photo published online)

  Pantoprazole sodium is a key digestive category in the current Huadong Medicine product line. Huadong Medicine has long been dedicated to technological innovation and international certification. The pantoprazole sodium and key preparation technologies research and industrialization project is the optimal carrier of coordinated innovation and industrialization and research at Huadong Medicine. This technological project has made major breakthroughs in overcoming multiple technological barriers and industrial problems, greatly improving product quality. Independent intellectual property rights protection has been formed and the product price has been effectively reduced, providing support for the development and application of key generic industry technology.

  This award is an indication of market approval for the innovative capabilities, advancement of preparation products and industrialization outcomes seen at Huadong Medicine. Meanwhile, it is anticipated that Huadong Medicine will further improve its brand influence and market competitiveness in the future, allowing it to further expand its market share. The company will continue to improve its product technologies and process level to carry out effective innovation and transformation.